References
- Cheng Q, Chen M, Liu M et al. (2022) Semaphorin 5A suppresses ferroptosis through activation of PI3K-AKT-mTOR signaling in rheumatoid arthritis. Cell Death Dis 13:608.
https://doi.org/10.1038/s41419-022-05065-4 - Chen K, Zeng H, Togizbayev G et al. (2023) New classification criteria for juvenile idiopathic arthritis. Int J Rheum Dis 26:1889–1892.
https://doi.org/10.1111/1756-185X.14813 - Gras C, Eiz-Vesper B, Jaimes Y et al. (2014) Secreted semaphorin 5A activates immune effector cells and is a biomarker for rheumatoid arthritis. Arthritis Rheumatol 66:1461–1471.
https://doi.org/10.1002/art.38425 - Petty RE, Southwood TR, Manners P et al. (2004) International league of associations for rheumatology classification of juvenile idiopathic arthritis: Second revision, Edmonton, 2001. J Rheumatol 31:390–392. PMID: 14760812.
- Qin Y, Jin J, Zhang J et al. (2023) A fully human monoclonal antibody targeting Semaphorin 5A alleviates the progression of rheumatoid arthritis. Biomed Pharmacother 168:115666.
https://doi.org/10.1016/j.biopha.2023.115666 - Sadanandam A, Rosenbaugh EG, Singh S et al. (2010) Semaphorin 5A promotes angiogenesis by increasing endothelial cell proliferation, migration, and decreasing apoptosis. Microvasc Res 79:1–9.
https://doi.org/10.1016/j.mvr.2009.10.005 - Świdrowska-Jaros J, Smolewska E (2018) A fresh look at angiogenesis in juvenile idiopathic arthritis. Centr Eur J Immunol 43:325–330.
https://doi.org/10.5114/ceji.2018.80052 - Xiao C, Lv C, Sun S et al. (2021) TSP1 is the essential domain of SEMA5A involved in pannus formation in rheumatoid arthritis. Rheumatology 60:5833–5842.
https://doi.org/10.1093/rheumatology/keab133 - Zaripova LN, Midgley A, Christmas SE et al. (2021) Juvenile idiopathic arthritis: From aetiopathogenesis to therapeutic approaches. Pediatr Rheumatol Online J 19:135.
https://doi.org/10.1186/s12969-021-00629-8